Homocysteine and cognitive function in elderly people
Open Access
- 12 October 2004
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 171 (8) , 897-904
- https://doi.org/10.1503/cmaj.1031586
Abstract
DEMENTIA IS HIGHLY PREVALENT AMONG ELDERLY PEOPLE, and projections show that the number of people affected might triple over the next 50 years, mainly because of a large increase in the oldest-old segment of the population. Because of this and the disease's devastating effects, measures for the prevention and early detection of dementia are crucial. Age and years of education are among the most relevant risk factors for dementia, but in recent years the role of homocysteine has also been investigated. Homocysteine is an amino acid produced in the metabolism of methionine, a process dependent on the B vitamins cobalamin, vitamin B6 and folic acid. There is evidence that increased serum homocysteine levels are associated with declining cognitive function and dementia. We review this evidence in addition to the potential mechanisms through which homocysteine acts on the brain to cause cognitive dysfunction, the metabolism of homocysteine and factors associated with alteration of the normal metabolism.This publication has 71 references indexed in Scilit:
- Cobalamin Reduces Homocysteine in Older Adults on Folic Acid–Fortified Diet: A Pilot, Double‐Blind, Randomized, Placebo‐Controlled TrialJournal of the American Geriatrics Society, 2004
- Homocysteine and Cerebral Infarction in Finnish Male SmokersStroke, 2003
- Low Vitamin B6 but Not Homocyst(e)ine Is Associated With Increased Risk of Stroke and Transient Ischemic Attack in the Era of Folic Acid Grain FortificationStroke, 2003
- Homocysteine and Risk of Recurrent StrokeStroke, 2003
- Prospective Study of Serum Homocysteine and Risk of Ischemic Stroke Among Patients With Preexisting Coronary Heart DiseaseStroke, 2003
- Total Plasma Homocysteine, Age, Systolic Blood Pressure, and Cognitive Performance in Older PeopleJournal of the American Geriatrics Society, 2002
- Is Low‐Dose Oral Cobalamin Enough to Normalize Cobalamin Function in Older People?Journal of the American Geriatrics Society, 2002
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine ConcentrationsNew England Journal of Medicine, 1999
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995